Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This is a combination of two medications used to treat allergic conditions, particularly allergic rhinitis (hay fever).\n\n**Cetirizine hydrochloride** is an antihistamine that helps relieve allergy symptoms such as runny nose, itchy or watery eyes, sneezing, and itching. It works by blocking histamine, a substance in the body that causes allergic symptoms.\n\n**Budesonide** is a corticosteroid that reduces inflammation in the nasal passages. When used as a nasal spray, it helps relieve symptoms such as stuffy nose, runny nose, and sneezing associated with allergic rhinitis.\n\nThe combination provides complementary mechanisms of action, with cetirizine addressing the histamine-mediated symptoms and budesonide reducing the inflammatory response.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on cetirizine hydrochloride + budesonide.